Dec 12, 2012 6:54 PM GMT
Tempting at only $99.
Anne Wojcicki wants to change the face of health care, and she believes that with the latest round of fundraising for her company 23andMe she can do just that.
23andMe, the personal genetics company founded by Anne Wojcicki, has raised $50 million in Series D financing from investors including Russian venture capitalist Yuri Milner, Wojcicki and her husband Google co-founder Sergey Brin, New Enterprise Associates, MPM Capital, and Google Ventures.
"This investment is transformative in that it will help us create a data platform that can be easily searched and used by researchers all over the world," Wojcicki tells FORTUNE.
With the financing in place, 23andMe has dropped the price of a personal genetics test to $99 from $299; and executives hope the move will push the company's user base to 1 million customers in 2013, up from 180,000. This would give the six-year-old company one of the world's largest private databases of genetic information.